Rare diseases
Investigational molecules
Locations
Piazzale Alessandro Ricchi 1, 09121 Cagliari, Italy
ARNAS G. Brotzu in Cagliari, Italy specialises in clinical trials of conditions such as Colitis ulcerative, Chronic lymphocytic leukaemia, Crohn's disease, Plasma cell myeloma, and other specialisations. This site conducts important research.
Clinical research at this site includes studies in digestive system diseases, with a strong focus on ulcerative colitis. These trials are designed to evaluate new treatment approaches and improve symptom control, endoscopic healing, and overall disease management for patients living with chronic intestinal inflammation.
The work in this area reflects ongoing efforts to refine care for inflammatory bowel disease and make treatments more effective in everyday practice.
Another important area at this hospital is cardiovascular disease research, especially studies involving stroke and urgent brain bleeding events. The trials aim to determine whether established treatments can improve survival and support better decision-making in acute care settings.
This research is focused on improving outcomes for patients with time-critical neurological and vascular conditions.
Clinical trials in hemic and lymphatic diseases at ARNAS G. Brotzu include research on early stage follicular lymphoma. These studies are designed to compare treatment strategies and determine whether combining therapies can improve disease control and long-term outcomes.
The goal is to support more effective cancer care by finding better ways to manage lymphoma in its earlier stages.
This research portfolio also highlights broader work in inflammatory bowel disease, with trials focused on moderately to severely active ulcerative colitis. The studies aim to test new medicines and assess whether they can bring meaningful clinical benefit for people whose disease remains difficult to control.
Overall, the site contributes to advancing care for chronic gastrointestinal conditions through research on treatment effectiveness and patient outcomes.
Clinical trials currently enrolling participants at this site.
A study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
ItalyA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
ItalyA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
ItalyA study testing duvakitug for patients with moderately to severely active ulcerative colitis
ItalyStudy on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis
ItalyTreatment Study of Arsenic Trioxide, Tretinoin, and Gemtuzumab Ozogamicin for Children and Adolescents with Acute Promyelocytic Leukemia
ItalyStudy of icotrokinra for adults with moderately to severely active Crohn's disease
ItalyA Study of Maribavir for Cytomegalovirus Infection in Stem Cell Transplant Patients Who Cannot Take or Did Not Tolerate Standard Treatment
ItalyA study testing intranasal esketamine compared to midazolam for rapidly reducing symptoms of major depressive disorder in adolescents with suicidal thoughts or behavior
ItalyStudy of ficerafusp alfa and pembrolizumab as first treatment for patients with PD-L1-positive recurrent or metastatic head and neck cancer
ItalyStudy of sonrotoclax plus obinutuzumab or rituximab compared to venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia
ItalyStudy on Venetoclax, Obinutuzumab, and Pirtobrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ItalyGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
